04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP.
In the rat sciatic nerve, the relationship between Schwann cells, axons, the extracellular matrix and perineurial sheath cells undergoes extensive modification between embryo day 15 and the onset of myelination during the first postnatal day. Little is known about molecular changes in Schwann cells in this important prenatal period. In the present paper, we use immunofluorescence to study the prenatal development and postnatal regulation of the antigen(s) recognized by the 04 monoclonal antibody and a well-characterized rat monoclonal antibody to sulfatide, A007. We show that, in a series of immunochemical tests, the 04 antibody recognizes only sulfatide in neonatal and adult rat nerves. Both antibodies first bind to Schwann cells in the sciatic nerve at embryo day 16-17, and all Schwann cells bind both antibodies at birth. In the adult nerve, both nonmyelin-forming and myelin-forming cells are labelled with the antibodies. Schwann cells dissociated from embryo day 15 nerves and cultured in the absence of axons develop neither 04 nor A007 binding on schedule, and 04-positive and A007-positive Schwann cells from postnatal nerves lose the ability to bind these antibodies during the first few days in culture. Schwann cells in the distal stump of transected nerves also sharply down-regulate cell surface binding of 04. High numbers of 04-positive or A007-positive Schwann cells reappear in cultures treated with agents that mimic or elevate intracellular cAMP. We conclude that two anti-sulfatide antibodies 04 and A007, recognize an antigen, probably sulfatide, that appears very early in Schwann cell development (one to two days prior to galactocerebroside) but is nevertheless subject to upregulation by axonal contact or elevation of intracellular cAMP.
Mirsky
R
R
Department of Anatomy and Developmental Biology, University College London, UK.
Dubois
C
C
Morgan
L
L
Jessen
K R
KR
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000943:Antigens, Differentiation / Q000378:metabolism; D001369:Axons / Q000378:metabolism*; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D005699:Galactosylceramides / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012583:Schwann Cells / Q000276:immunology / Q000378:metabolism*; D012584:Sciatic Nerve / Q000196:embryology; D015398:Signal Transduction; D013433:Sulfoglycosphingolipids / Q000032:analysis* / Q000276:immunology
D000906:Antibodies; D000943:Antigens, Differentiation; D005699:Galactosylceramides; D013433:Sulfoglycosphingolipids; C002454:galactocerebroside; D000242:Cyclic AMP